Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Jacob Schuringa

Showing results (91-100 of 146) with videos related to

Pageof 15
Sort By:
Leukemia Research|April 8, 2019
Not type of induction therapy but consolidation with allogeneic hematopoietic cell transplantation determines outcome in older AML patients: A single center experience of 355 consecutive patientsJacobien Hilberink, Carin Hazenberg, Eva van den Berg, et al.
Cancer & Metabolism|January 1, 2020
HIF1/2-exerted control over glycolytic gene expression is not functionally relevant for glycolysis in human leukemic stem/progenitor cellsAlbertus T J Wierenga, Alan Cunningham, Ayşegül Erdem, et al.
Experimental Hematology & Oncology|March 30, 2024
VISTA drives macrophages towards a pro-tumoral phenotype that promotes cancer cell phagocytosis yet down-regulates T cell responsesYusheng Lin, Ghizlane Choukrani, Lena Dubbel, et al.
Cancer Research|March 31, 2011
Repression of vascular endothelial growth factor expression by the runt-related transcription factor 1 in acute myeloid leukemiaArja Ter Elst, Bin Ma, Frank J G Scherpen, et al.
Blood Advances|August 30, 2021
Peripheral blood cytopenias in the aging general population and risk of incident hematological disease and mortalityIsabelle A van Zeventer, Aniek O de Graaf, Melanie M van der Klauw, et al.
Cell Cycle (Georgetown, Tex.)|May 20, 2011
Zinc finger protein 521 antagonizes early B-cell factor 1 and modulates the B-lymphoid differentiation of primary hematopoietic progenitorsTiziana Mega, Michela Lupia, Nicola Amodio, et al.
Journal of Thrombosis and Haemostasis : JTH|May 27, 2026
Novel SERPINC1 variants in hereditary Antithrombin Deficiency: first pathogenic deep-intronic variant, revealed by multiple genomic and transcriptomic approachesP Christian Remmelzwaal, René Mulder, Jelkje J de Boer-Bergsma, et al.
Blood Advances|April 20, 2021
Prevalence, predictors, and outcomes of clonal hematopoiesis in individuals aged ≥80 yearsIsabelle A van Zeventer, Jonas B Salzbrunn, Aniek O de Graaf, et al.
Blood Advances|September 20, 2021
CombiFlow: combinatorial AML-specific plasma membrane expression profiles allow longitudinal tracking of clonesRoos Houtsma, Nisha K van der Meer, Kees Meijer, et al.
Nucleic Acids Research|June 11, 2026
Sustained PRC1.1 activity preserves gene repression independently of PRC2.2 and restrains leukemic cell differentiationFatemeh Mojallali, Alessandra De Meis, Sinne G Alkema, et al.
Pageof 15

Showing results (91-100 of 146) with videos related to

Sort By:
Pageof 15
Leukemia Research|April 8, 2019
Not type of induction therapy but consolidation with allogeneic hematopoietic cell transplantation determines outcome in older AML patients: A single center experience of 355 consecutive patientsJacobien Hilberink, Carin Hazenberg, Eva van den Berg, et al.
Cancer & Metabolism|January 1, 2020
HIF1/2-exerted control over glycolytic gene expression is not functionally relevant for glycolysis in human leukemic stem/progenitor cellsAlbertus T J Wierenga, Alan Cunningham, Ayşegül Erdem, et al.
Experimental Hematology & Oncology|March 30, 2024
VISTA drives macrophages towards a pro-tumoral phenotype that promotes cancer cell phagocytosis yet down-regulates T cell responsesYusheng Lin, Ghizlane Choukrani, Lena Dubbel, et al.
Cancer Research|March 31, 2011
Repression of vascular endothelial growth factor expression by the runt-related transcription factor 1 in acute myeloid leukemiaArja Ter Elst, Bin Ma, Frank J G Scherpen, et al.
Blood Advances|August 30, 2021
Peripheral blood cytopenias in the aging general population and risk of incident hematological disease and mortalityIsabelle A van Zeventer, Aniek O de Graaf, Melanie M van der Klauw, et al.
Cell Cycle (Georgetown, Tex.)|May 20, 2011
Zinc finger protein 521 antagonizes early B-cell factor 1 and modulates the B-lymphoid differentiation of primary hematopoietic progenitorsTiziana Mega, Michela Lupia, Nicola Amodio, et al.
Journal of Thrombosis and Haemostasis : JTH|May 27, 2026
Novel SERPINC1 variants in hereditary Antithrombin Deficiency: first pathogenic deep-intronic variant, revealed by multiple genomic and transcriptomic approachesP Christian Remmelzwaal, René Mulder, Jelkje J de Boer-Bergsma, et al.
Blood Advances|April 20, 2021
Prevalence, predictors, and outcomes of clonal hematopoiesis in individuals aged ≥80 yearsIsabelle A van Zeventer, Jonas B Salzbrunn, Aniek O de Graaf, et al.
Blood Advances|September 20, 2021
CombiFlow: combinatorial AML-specific plasma membrane expression profiles allow longitudinal tracking of clonesRoos Houtsma, Nisha K van der Meer, Kees Meijer, et al.
Nucleic Acids Research|June 11, 2026
Sustained PRC1.1 activity preserves gene repression independently of PRC2.2 and restrains leukemic cell differentiationFatemeh Mojallali, Alessandra De Meis, Sinne G Alkema, et al.
Pageof 15